IMR Press / EJGO / Volume 36 / Issue 3 / DOI: 10.12892/ejgo2647.2015

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research
30 years of preventive studies of uterine cervical cancer 1982–2012
Show Less
1 Clinica Hospital of Medical Specialties Chemsa, Panama City (Republic of Panama)
Eur. J. Gynaecol. Oncol. 2015, 36(3), 252–254; https://doi.org/10.12892/ejgo2647.2015
Published: 10 June 2015
Abstract

The studies for the prevention of uterine cervical cancer in Panama City began in a private institute, impelled by the high incidence of cancer. The preventive programs were initiated with the support of the Obstetrics and Gynecology Institute of the University of Padua n Italy. In these studies, we applied the methodological diagnostics of this Institute with certain modifications adapted to our needs. The diagnosis, treatment, and follow-up were carried out under the protocol of the University of Padua. We achieved a diagnosis of oncogenic isk (OR) in 6,411 patients which corresponded to 5,498 cases of human papillomavirus (HPV), 1,150 cases of dysplasia, 210 cases of cancer, and 794 cases of OR. From 2011, polymerase chain reaction (PCR) was also applied with the aim to improve the accuracy f the diagnosis. With this method the prevalence of pathologies were HPV infections both in healthy patients or in patients cured from PV. Patients were treated by means of local destructive treatments (LDT), basically with cryotherapy and cauterization. We can consider hese results as successful prevention and suggest to extend a preventive program to all the population.
Keywords
Oncogenic risk prevention
Cervical cancer: Treatment evolution
Share
Back to top